VIE Equity Snapshot

LKFT Weekly Equity Report

Lakefront Biotherapeutics NV

Interactive chart JSON snapshot
Latest Close 25.08 EUR 12 Jun 2026
1W Return 2.8% latest completed week
4W Return 6.0% short-term follow-through
12W Return -10.3% quarterly tape
Trend Breadth 63.5% 33 of 52 weeks active
Volume Ratio - vs 13-week average
Company Brief

What the company does

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and …

Snapshot

What the weekly tape is saying

LKFT closed the latest completed week at 25.08 EUR. The 4-week return is 6.0% and the 12-week return is -10.3%. Trend Signal is inactive, Market Dynamics is -0.84. Setup signature: Risk-first tape with a 28/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -5.8%
Volume -
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 35 Persistence of active Trend Signal over the last year and current streak.
Momentum 55 Blend of 4-week and 12-week follow-through.
Dynamics 38 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 0 Participation compared with the 13-week volume baseline.
Risk Control 39 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
26.62 EUR
Vs Trend Line
-5.8%
Fair Value
28.21 EUR
Vs Fair Value
-11.1%
52W High
32.20 EUR
52W Low
22.68 EUR
Drawdown
-22.1%
Range Position
25.2%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 2.8%
4W 6.0%
12W -10.3%
26W -8.5%
52W 0.6%

Trend read

Active Streak
0 weeks
52W Active Weeks
33
52W Active Breadth
63.5%
Sector Scope
AT Healthcare
Sector Rank
18 of 112
Sector Percentile
84.7%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.84
4W MD Change
37.7%
Relative Strength
-24.19
4W RS Change
5.1%
Expectation
Negative
Probability
44.01%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
0
13W Average
430
52W Average
571
Vs 13W
-
Vs 52W
-
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.0%
52W Volatility
3.4%
Upside Weeks
27
Downside Weeks
24
Downside Breadth
46.2%
Avg Gain / Loss
2.3% / -2.4%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
VIE
Country
AT
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Market Cap
1.6B

Opportunity signals

  • Latest weekly return ranks in the strongest part of its sector group.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 25.08 EUR 2.8% 26.62 EUR 28.21 EUR -0.84 -24.19 0 Off
5 Jun 2026 24.40 EUR 0.0% 26.67 EUR 28.30 EUR -1.06 -24.60 273 Off
29 May 2026 24.40 EUR 2.4% 26.78 EUR 28.39 EUR -1.13 -25.80 0 Off
22 May 2026 23.82 EUR 0.7% 26.87 EUR 28.49 EUR -1.24 -26.04 1.4K Off
15 May 2026 23.66 EUR 0.5% 27.00 EUR 28.60 EUR -1.36 -25.48 362 Off
8 May 2026 23.54 EUR -2.1% 27.19 EUR 28.71 EUR -1.40 -26.53 2.1K Off
1 May 2026 24.04 EUR -2.6% 27.37 EUR 28.78 EUR -1.51 -24.16 0 Off
24 Apr 2026 24.68 EUR -0.6% 27.62 EUR 28.85 EUR -1.53 -22.06 0 Off
17 Apr 2026 24.82 EUR 1.0% 27.72 EUR 28.91 EUR -1.49 -24.70 0 Off
10 Apr 2026 24.58 EUR -3.5% 27.86 EUR 28.97 EUR -1.21 -23.94 0 Off
3 Apr 2026 25.46 EUR 0.2% 27.96 EUR 29.03 EUR -0.73 -16.51 0 Off
27 Mar 2026 25.42 EUR -9.1% 28.03 EUR 29.09 EUR -0.30 -14.02 1.1K Off
20 Mar 2026 27.96 EUR -2.8% 28.10 EUR 29.15 EUR 0.24 -4.31 369 On
13 Mar 2026 28.76 EUR 2.0% 28.09 EUR 29.19 EUR 0.49 -2.92 575 On